Nathachit Limjunyawong

Dr. Nathachit Limjunyawong

siCORE-Allergy and Immunology, Faculty of medicine siriraj hospital, Mahidol university, Bangkok, Krung Thep Maha Nakhon, Thailand
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Neuron
Verified
Journal Article
Closed access
DGDustin P. Green
Dustin P. Green
NLNathachit Limjunyawong
Nathachit Limjunyawong
NGNaina Gour
Naina Gour
PPPriyanka Pundir
Priyanka Pundir
XDXinzhong Dong
Xinzhong Dong

1 May 2019 in Immunity
Verified
Journal Article
Closed access
JMJames Meixiong
James Meixiong
MAMichael Anderson
Michael Anderson
NLNathachit Limjunyawong
Nathachit Limjunyawong
MSMark F. Sabbagh
Mark F. Sabbagh
EHEric Hu
Eric Hu
XDXinzhong Dong
Xinzhong Dong

3 April 2015 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JAJonathan K. Alder
Jonathan K. Alder
CBChristina E. Barkauskas
Christina E. Barkauskas
NLNathachit Limjunyawong
Nathachit Limjunyawong
SSSusan E. Stanley
Susan E. Stanley
FKFrant Kembou
Frant Kembou
MAMary Armanios
Mary Armanios
Significance: Idiopathic pulmonary fibrosis and emphysema are leading causes of mortality, but there are no effective therapies. Mutations in telomerase are the most common identifiable risk factor for idiopathic pulmonary fibrosis. They also predispose to severe emphysema in smokers, occurring at a frequency similar to α-1 antitrypsin deficiency. The work shown here points to alveolar stem cell senescence as a driver of these pathologies. Epithelial stem cell failure was associated with secondary inflammatory recruitment and exquisite susceptibility to injury from “second hits.” The findings suggest that efforts to reverse the stem cell failure state directly, rather than its secondary consequences, may be an effective therapy approach in telomere-mediated lung disease.

21 May 2014 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
JMJ R Mock
J R Mock
BGB T Garibaldi
B T Garibaldi
NAN R Aggarwal
N R Aggarwal
JJJ Jenkins
J Jenkins
NLNathachit Limjunyawong
Nathachit Limjunyawong
FDF R D'ALessio
F R D'ALessio
Acute respiratory distress syndrome (ARDS) causes significant morbidity and mortality each year. There is a paucity of information regarding the mechanisms necessary for ARDS resolution. Foxp3+ regulatory T cells (Foxp3+ Treg cells) have been shown to be an important determinant of resolution in an experimental model of lung injury. We demonstrate that intratracheal delivery of endotoxin (lipopolysaccharide) elicits alveolar epithelial damage from which the epithelium undergoes proliferation and repair. Epithelial proliferation coincided with an increase in Foxp3+ Treg cells in the lung during the course of resolution. To dissect the role that Foxp3+ Treg cells exert on epithelial proliferation, we depleted Foxp3+ Treg cells, which led to decreased alveolar epithelial proliferation and delayed lung injury recovery. Furthermore, antibody-mediated blockade of CD103, an integrin, which binds to epithelial expressed E-cadherin decreased Foxp3+ Treg numbers and decreased rates of epithelial proliferation after injury. In a non-inflammatory model of regenerative alveologenesis, left lung pneumonectomy, we found that Foxp3+ Treg cells enhanced epithelial proliferation. Moreover, Foxp3+ Treg cells co-cultured with primary type II alveolar cells (AT2) directly increased AT2 cell proliferation in a CD103-dependent manner. These studies provide evidence of a new and integral role for Foxp3+ Treg cells in repair of the lung epithelium.

1 July 2019 in Cell Host & Microbe
Verified
Journal Article
Closed access
PPPriyanka Pundir
Priyanka Pundir
RLRui Liu
Rui Liu
Chirag VasavdaChirag Vasavda
Chirag Vasavda
NSNadine Serhan
Nadine Serhan
NLNathachit Limjunyawong
Nathachit Limjunyawong
XDXinzhong Dong
Xinzhong Dong

8 November 2021 in Neuron
Verified
Journal Article
Closed access
QZQin Zheng
Qin Zheng
WXWenrui Xie
Wenrui Xie
DLDebora D. Lückemeyer
Debora D. Lückemeyer
MLMark Lay
Mark Lay
XWXue-Wei Wang
Xue-Wei Wang
XDXinzhong Dong
Xinzhong Dong